WASHINGTON — In the final weeks before Tuesday’s midterm elections, the pharmaceutical industry’s campaign donations began flowing heavily and unexpectedly in a new direction: toward Democrats.
The party received a full 63 percent of the industry’s campaign contributions reported in the first half of October, according to data compiled by the Center for Responsive Politics. That’s a new trend to cap off a tumultuous election cycle: Up to this point, just over half of drug industry money has flowed toward Republicans, and the GOP has received substantially more campaign cash from the pharmaceutical and health products industry in the past decade.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author
